-
PrimeC – Positive Results in Phase IIa Clinical Study in ALS
Hi All,
NeuroSense Therapeutics recently reported positive results in a PrimeC clinical study in ALS, announcing the successful completion of its first Phase IIa study. The successful completion of this trial paves the way for PrimeC to become a leading candidate in the fight against ALS.
Is this more hype or hope?
Richard
-
1 Reply
-
Just read that Phase 2 PrimeC trial is showing significant slower symptom progression. And that a patent of the 2 drug combination was recently approved and that a phase 3 trial will be forthcoming. Would like to know more about the upcoming trial- will additional PALS be able to enter?
Log in to reply.